Evaluation of the "Coping Long Term with Active Suicide Program"

“应对长期积极自杀计划”的评价

• 批准号: 8857554
• 负责人: IVAN W. MILLER
• 金额: $ 55.32万
• 依托单位: BUTLER HOSPITAL (PROVIDENCE, RI)
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-06-09 至 2019-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8857554
• 关键词: Accounting; Area; Caring; Case Management; Centers for Disease Control and Prevention (U.S.); Cessation of life; Clinical Trials; Communities; Conduct Clinical Trials; Country; Data; Diagnosis; Effect Modifiers (Epidemiology); Elements; Evaluation; Family psychotherapy; Feeling suicidal; Gender; Grant; Growth; Health; Hospitalization; Hospitals; Individual; Inpatients; Intervention; Knowledge; Mental Health; Mental disorders; Modeling; National Institute of Mental Health; Outcome; Patients; Phase; Population; Psychiatric Hospitals; Psychiatric therapeutic procedure; Psychotherapy; Public Health; Randomized; Randomized Clinical Trials; Recording of previous events; Research; Safety; Sampling; Severities; Suicide; Suicide attempt; Suicide prevention; Symptoms; Telephone; Testing; United States; accomplished suicide; base; coping; design; follow-up; high risk; innovation; intervention program; programs; psychosocial; suicidal; suicidal behavior; suicidal risk; suicide rate; therapy design; therapy development; treatment as usual

DESCRIPTION (provided by applicant): Suicide and attempted suicide are major public health issues in the United States, with suicide accounting for more than 36,000 deaths in the year 2009, and over 500,000 attempt suicide each year. Although recent years have seen significant advances in our knowledge of efficacious treatments for many psychiatric disorders, the suicide rates in this country have not decreased substantially. Despite the high public health significance of suicide and the apparent inability of our current psychiatric treatments to influence suicide rates, there has been relatively little research devoted to developing or testing interventions that directly target suicidal behavior. Developing and evaluating new interventions to reduce suicidal behavior has been recognized as a priority area by NIMH, CDC and the recently released 2012 National Strategy for Suicide Prevention. Supported by previous treatment development grants, we have developed a new intervention as an adjunct to community treatment specifically designed to reduce suicidal behavior among high-risk populations This intervention, "Coping Long Term with Active Suicide Program" (CLASP) is an innovative, telephone based intervention, which combines elements of individual psychotherapy, case management and significant other/family therapy. Pilot data on the CLASP intervention have been quite promising. Patients admitted to a psychiatric hospital due to suicide risk who received CLASP had two-thirds fewer suicide attempts than those receiving a control condition during a six month follow-up following hospital discharge. This application proposes to conduct a larger scale clinical trial evaluating the effects of the adjunctive CLASP intervention to reduce suicidal behavior. More specifically, we propose to randomly assign 232 patients admitted to a psychiatric hospital due to a suicide attempt or suicide risk to either the CLASP intervention or an Safety Assessment and Follow-up Evaluation (SAFE) comparison, both delivered as adjuncts to community treatment as usual. We propose to conduct follow-up assessments at both at the end of the active intervention phase (6 months post-discharge from hospital) and again at 9 and 12 months post discharge.

描述（由申请人提供）：自杀和自杀未遂是美国主要的公共卫生问题，2009年有超过36,000人死于自杀，每年有超过500,000人企图自杀。尽管近年来我们在许多精神疾病的有效治疗方面取得了重大进展，但这个国家的自杀率并没有大幅下降。尽管自杀对公共健康的重要性很高，而且我们目前的精神病治疗显然无法影响自杀率，但致力于开发或测试自杀率的研究相对较少